Dallas, Texas 08/01/2013 (Financialstrend) - Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) is concentrated in development of drugs for the treatment of gastrointestinal infections and related diseases. CEM-101 (OP-1068) and OPT-822/821 are the company’s two principal products. There had been an inquiry on the company related to whether the Optimer directors are...
Dallas, Texas 08/01/2013 (Financialstrend) - Trius Therapeutics, Inc. (NYSE:TSRX) had presented gains of 20.41% with the trading on Wednesday and had thereby closed at $14.10 per share. While the stock opened at $13.75 per share, there had been fluctuations in the intraday prices ranging between $13.50 and $14.17 per...
Dallas, Texas 08/01/2013 (Financialstrend) - Shares of Boston Scientific had recently been gaining in prices with the price targets and ratings given to the stock being boosted up by the analysts in the market. Boston Scientific Corporation (NYSE:BSX) had presented gains of 0.83% with the trading on Wednesday and...
Dallas, Texas 08/01/2013 (Financialstrend) - Questcor Pharmaceuticals Inc (NASDAQ:QCOR) is concentrated on the development of therapeutics to cure inflammatory disorders and autoimmune diseases.  H.P. Acthar Gel is the company’s primary product. The company acquired Novartis AG. Both together have increased the stock value by up to 15%. Acthar was...
Dallas, Texas 08/01/2013 (Financialstrend) - Accounting procedures related to the major restructuring operations planned by Pfizer Inc. (NYSE:PFE) had proved to be effective to boost up the company from its worse expected results for the second quarter of this fiscal year. The largest drug maker in the United States...
Dallas, Texas 07/31/2013 (Financialstrend) - Stereotaxis, Inc. (NASDAQ:STXS) announced that its Vdrive Robotic Navigation System with V-Sono(TM) Intracardiac Echocardiography catheter manipulator got approval to market in United States from Food and Drug Administration (FDA) with a grant of 510(k) clearance, following this announcement the company surged a great height with the...
Dallas, Texas 07/31/2013 (Financialstrend) - Increase in net income and profits reported for the second quarter of the fiscal year by Boston Scientific Corporation (NYSE:BSX) had proved to be of value to the shareholders who had been flocking to the stock in the recent days. There had been reported...
Dallas, Texas 07/30/2013 (Financialstrend) - Maestro® Rechargeable System's vagal blocking therapy VBLOC® was submitted for the pre market approval to the Federal Drug Administrator (FDA) of the United States by EnteroMedics, the developer of the medical devices which are used for the treatment of obesity, gastrointestinal diseases and metabolic...
Dallas, Texas 07/30/2013 (Financialstrend) - For the second quarter of the fiscal year 2013, Boston Scientific Corporation (NYSE:BSX) had reported higher level of net income and profits to boost up the investors to flock to this stock in the recent days of trading. The company had reported significant improvement...
Dallas, Texas 07/29/2013 (Financialstrend) - Merck & Co., Inc. (NYSE:MRK) closed in the previous trading session at $48.49 after going 0.66% (or +$0.32) in the northwards direction. The stock has hit day’s high at $48.49 and day’s low at $47.78. Merck & Co., also known as MSD outside the Canada...